May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
OCT versus Fluorescein Angiography for the Assessment of ARMD Juxtafoveal Visible Choroidal Newvessels Treated by Krypton Laser and Risk Factors for Recurrences.
Author Affiliations & Notes
  • C.M. Favard
    Ophthalmology, Rothschild Foundation, Paris, France
  • C. Francais
    Ophthalmology, CNO 15/20, Paris, France
  • A. El Maftouhi
    Ophthalmology, CNO 15/20, Paris, France
  • M. Assouline
    Ophthalmology, Clinique de la Vision, Paris, France
  • G. Caputo
    Ophthalmology, Rothschild Foundation, Paris, France
  • L. Laroche
    Ophthalmology, CNO 15/20, Paris, France
  • G. Coscas
    Ophthalmology, Centre de l'Odeon, Paris, France
  • Footnotes
    Commercial Relationships  C.M. Favard, None; C. Francais, None; A. El Maftouhi, None; M. Assouline, None; G. Caputo, None; L. Laroche, None; G. Coscas, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 1400. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C.M. Favard, C. Francais, A. El Maftouhi, M. Assouline, G. Caputo, L. Laroche, G. Coscas; OCT versus Fluorescein Angiography for the Assessment of ARMD Juxtafoveal Visible Choroidal Newvessels Treated by Krypton Laser and Risk Factors for Recurrences. . Invest. Ophthalmol. Vis. Sci. 2005;46(13):1400.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To compare OCT and Fluorescein Angiography for the assessment of ARMD juxtafoveal visible choroidal newvessels (VCNV) treated by krypton laser. To identify risk factors for long term recurrences. Methods: Prospective 1 year study of ETDRS visual acuity, FA and OCT before krypton laser treatement and at 2 weeks, 3, 6 and 12 months or more. Results: 16 of 19 eyes were followed more than 1 year. Recurrences were observed after 7.7 ± 3.8 months in 8 eyes, including visible CNV (n=3), occult CNV (n=3) and mixed CNV (n=2). As compared to FA, OCT showed a larger diameter (p=0.009) and foveolar extension (p=0.0001) of preoperative VCNV. This difference was highly significant for eyes in which a recurrence was observed, both for diameter (p=0.0008) and for foveolar extension (p=0.0006) but was not significant for eyes that remained stable after treatment. These recurrences were treated by PDT in 6 eyes, resulting in stabilization of VA in 4 eyes. Conclusions: The hyperreflective signal of VCNV observed on OCT, which appears to extend further than the vascular membrane measured with FA may represent an unidentified histopathological component of CNV (either a fibrous reaction preceding vascularization, or non circulating / occult vessel), and may be indicative of a higher risk of recurrence after laser treatment.

Keywords: laser • retina • retinal neovascularization 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×